- Home
- UTL vs CATX Comparison
UTL vs CATX Comparison
Compare UTL & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTL
- CATX
- Stock Information
- Founded
- UTL 1984
- CATX 1983
- Country
- UTL United States
- CATX United States
- Employees
- UTL N/A
- CATX N/A
- Industry
- UTL Power Generation
- CATX Medical/Dental Instruments
- Sector
- UTL Utilities
- CATX Health Care
- Exchange
- UTL Nasdaq
- CATX Nasdaq
- Market Cap
- UTL 915.6M
- CATX 782.7M
- IPO Year
- UTL N/A
- CATX N/A
- Fundamental
- Price
- UTL $56.20
- CATX $2.78
- Analyst Decision
- UTL
- CATX Strong Buy
- Analyst Count
- UTL 0
- CATX 9
- Target Price
- UTL N/A
- CATX $17.25
- AVG Volume (30 Days)
- UTL 60.1K
- CATX 724.0K
- Earning Date
- UTL 02-10-2025
- CATX 03-04-2025
- Dividend Yield
- UTL 3.20%
- CATX N/A
- EPS Growth
- UTL 3.86
- CATX N/A
- EPS
- UTL 2.93
- CATX N/A
- Revenue
- UTL $494,800,000.00
- CATX $1,557,000.00
- Revenue This Year
- UTL $16.37
- CATX N/A
- Revenue Next Year
- UTL $5.20
- CATX N/A
- P/E Ratio
- UTL $19.21
- CATX N/A
- Revenue Growth
- UTL N/A
- CATX N/A
- 52 Week Low
- UTL $47.40
- CATX $2.70
- 52 Week High
- UTL $63.52
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- UTL 58.10
- CATX 32.67
- Support Level
- UTL $54.23
- CATX $2.91
- Resistance Level
- UTL $57.24
- CATX $3.21
- Average True Range (ATR)
- UTL 1.12
- CATX 0.20
- MACD
- UTL 0.23
- CATX -0.03
- Stochastic Oscillator
- UTL 70.29
- CATX 1.75
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. It reports three segments namely utility gas operations, utility electric operations, and non-regulated.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.